Adlai Nortye Ltd.
NASDAQ:ANLBiotechnology
Healthcare
$8.74 -1.07%
-$0.11 today
- Market cap
- $463.92M
- Beta
- 0.99
- P/E (TTM)
- -3.0
- EPS (TTM)
- -$3.33
52W Low $0.88High $17.25
Volume 0.45M
Average 0.35M
Income Statement
Follow revenue through to earnings.
Revenue
$5.00M
FY 2025 · Annual
Operating Income
-$35.70M
FY 2025 · Annual
Net Income
-$35.53M
FY 2025 · Annual
Income Statement
USD
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 45.73M | 0 | 0 | 0 | 5M |
| Cost of Revenue | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 45.73M | 0 | 0 | 0 | 5M |
| Gross Margin | 100.0% | — | — | — | 100.0% |
| Research & Development | 42.11M | 54.49M | 58.15M | 44.92M | 32.83M |
| Selling, General & Admin | 12.45M | 12.43M | 14.82M | 9.44M | 7.79M |
| Operating Expenses | 54.37M | 67.27M | 72.55M | 52.93M | 40.7M |
| Depreciation & Amortization | 1.83M | 2.04M | 2.22M | 1.87M | 1.41M |
| EBITDA | (53.51M) | (56.32M) | (106.22M) | (48.06M) | (32.63M) |
| EBITDA Margin | -117.0% | — | — | — | -652.5% |
| Operating Income | (8.65M) | (67.27M) | (72.55M) | (52.93M) | (35.7M) |
| Operating Margin | -18.9% | — | — | — | -714.0% |
| Interest Income | 32K | 550K | 62K | 0 | 1K |
| Interest Expense | 1.34M | 433K | 791K | 1.94M | 1.49M |
| Other Income / Expenses | (48.03M) | 8.48M | (36.68M) | 1.06M | 170K |
| Income Before Tax | (56.68M) | (58.79M) | (109.23M) | (51.87M) | (35.53M) |
| Pre-Tax Margin | -124.0% | — | — | — | -710.6% |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 |
| Net Income | (56.68M) | (58.79M) | (109.23M) | (51.87M) | (35.53M) |
| Net Margin | -124.0% | — | — | — | -710.6% |
| EPS (Basic) | (6.66) | (6.93) | (15.42) | (4.89) | (3.33) |
| EPS (Diluted) | (6.66) | (6.93) | (15.42) | (4.89) | (3.33) |
| 8.48M | 8.48M | 6.8M | 10.64M | 10.66M | |
| 8.48M | 8.48M | 6.8M | 10.64M | 10.66M |
ANL Earnings Waterfall · TTM
NASDAQ:ANL · Revenue to Net Income
Key Ratios
EPS$-7.08
Gross Margin25.0%
Net Margin-463.3%
P/E Ratio-0.1
P/S Ratio10.6
Analysis
$6.5M of revenue converted into -$54.1M of net income for the selected period. Gross margin is 25.0% and net margin is -463.3%, showing how much revenue survives after costs and taxes. EPS is $-7.08, tying the income statement back to per-share earnings.
Competitors
Peer companies in the same sector
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 6-K | 6-K filing | Oct 28, 2026 | |
| 6-K | 6-K filing | Oct 15, 2026 | |
| 4 | Statement of changes in beneficial ownership | Oct 1, 2026 | |
| 6-K | 6-K filing | Sep 30, 2026 | |
| 6-K | 6-K filing | Sep 30, 2026 |
How much revenue does ANL generate?
Adlai Nortye Ltd. (ANL) reported $5.00M of revenue in fiscal 2025.
Is ANL profitable?
Adlai Nortye Ltd. (ANL) reported -$35.53M of net income, with a net margin of -710.6%.
Continue the stock analysis
Jump to another research area for this company.